- Home
- PRFX vs IMCC Comparison
PRFX vs IMCC Comparison
Compare PRFX & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRFX | IMCC |
|---|---|---|
| Founded | 2007 | 1980 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.7M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PRFX | IMCC |
|---|---|---|
| Price | $1.53 | $0.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.9K | ★ 371.3K |
| Earning Date | 03-26-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $63.88 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.58 | $0.22 |
| 52 Week High | $3.71 | $7.12 |
Technical Indicators
Market Signals| Indicator | PRFX | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 26.03 | 35.04 |
| Support Level | $1.26 | $0.23 |
| Resistance Level | $1.58 | $0.55 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 26.43 | 32.80 |
Price Performance
Historical ComparisonAbout PRFX PainReform Ltd.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasise reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the Company's lead product, is based on the local anaesthetic ropivacaine and targets the postoperative pain relief market.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.